(Q34292020)

1 August 2017

1 reference

title

Clinical aspects and management of AIDS-related Kaposi's sarcoma (English)

1 reference

AIDS-related Kaposi's sarcoma

1 August 2017

1 reference

Levine AM

1

1 reference

PubMed ID

11423260

1 August 2017

Tulpule A

series ordinal

2

1 reference

PubMed ID

11423260

1 August 2017

language of work or name

1 reference

1 July 2001

1 reference

European Journal of Cancer

1 August 2017

1 reference

1 August 2017

37

1 reference

1 August 2017

10

1 reference

1 August 2017

1288-1295

1 reference

Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Pulmonary Kaposi's sarcoma: clinical findings and results of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Tumor and infection localization in AIDS patients: Ga-67 and Tl-201 findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Clinical aspects of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Intralesional Chemotherapy for Kaposi’s Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Argon laser photocoagulative therapy of Kaposi's sarcoma: a clinical and histologic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Treatment of the acquired immune deficiency syndrome—related Kaposi's sarcoma with bleomycin as a single agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Treatment of Advanced Kaposiʼs Sarcoma Using a Combination of Bleomycin and Vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900109-5

7 January 2021

10.1016/S0959-8049(01)00109-5

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11423260